Pharmacogenetic intervention improves treatment outcomes in Chinese adult men with schizophrenia

精神分裂症(面向对象编程) 药物遗传学 干预(咨询) 心理学 精神科 梅德林 医学 临床心理学 基因型 遗传学 生物 基因 政治学 法学
作者
Ying Qin,Yanjing Liu,Jingwen Zhao,Yong Yang,Hui Xiang,Tianwei Gao,Chengchen Huang
出处
期刊:Journal of Psychiatric Research [Elsevier BV]
卷期号:174: 129-136 被引量:7
标识
DOI:10.1016/j.jpsychires.2024.04.020
摘要

To investigate the clinical application value of pharmacogenetic testing in individualized drug therapy for adult male patients with schizophrenia. A total of 186 adult patients with schizophrenia were enrolled and randomised into the pharmacogenetic (PGx) intervention group and the standard care group. In the PGx intervention group, PGx testing was performed, and the medication regimen was adjusted according to the results of the pharmacogenomic analysis. In contrast, in the standard care group, patients were treated according to the physician's medication experience. Differences in the primary indicator of schizophrenia, the Positive and Negative Symptom Scale (PANSS), and the secondary efficacy measures, the Clinical Global Impressions–Severity of Illness scale (CGI-SI) and Clinical Global Impressions–Global Improvement (CGI-GI) scale, were compared between the intervention and standard care groups. At baseline, the PGx intervention group consisted of 109 individuals, while the standard care group had 77 participants. After 12 weeks of treatment, 49 individuals withdrew from the PGx group (a dropout rate of 45.0%), and 34 withdrew from the standard care group (a dropout rate of 44.2%), with no significant difference in dropout rates between the two groups. The PANSS score reduction rate in the PGx intervention group significantly exceeded that of the standard care group during weeks 3, 6, and 12 of follow-up (P < 0.05). At the 12th week, the PGx intervention group achieved a treatment response rate of 81.7%, significantly surpassing the 48.8% of the standard care group (odds ratio of 4.67, 95% confidence interval of 1.96-11.41; P = 0.001). Furthermore, the PGx intervention was significantly more effective than standard care regardless of whether the patient had a first episode or a relapse (P < 0.05). Furthermore, the Global Assessment of Functioning (GAF) scores and the Personal and Social Performance Scale (PSP) score changes in the PGx intervention group were both significantly different from those in the standard care group (P < 0.05). It is noteworthy that the PGx intervention similarly improves the prognostic outcomes for patients with and without a family history of mental disorders. In conclusion, the application of a PGx intervention treatment model based on PGx testing can significantly improve medication efficacy and shorten the time to achieve the effects of medication in schizophrenia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT的应助被读书人采纳,获得10
刚刚
刚刚
kalah发布了新的文献求助50
刚刚
吃肯德基发布了新的文献求助10
刚刚
haoyun发布了新的文献求助30
1秒前
like发布了新的文献求助10
2秒前
2秒前
2秒前
121发布了新的文献求助10
3秒前
李健的应助被韩ck采纳,获得10
3秒前
极限001的应助被KKH采纳,获得30
4秒前
白玄发布了新的文献求助10
4秒前
5秒前
syy发布了新的文献求助10
5秒前
GARYJIANG发布了新的文献求助10
6秒前
7秒前
9秒前
ZRR发布了新的文献求助10
9秒前
10秒前
12秒前
anugraphics发布了新的文献求助20
12秒前
林佳明完成签到,获得积分10
13秒前
猪猪hero的应助被明理汲采纳,获得10
13秒前
龙魂完成签到,获得积分10
13秒前
lois发布了新的文献求助10
14秒前
regina发布了新的文献求助10
14秒前
14秒前
清爽煎蛋完成签到,获得积分20
14秒前
15秒前
所所的应助被感动的易真采纳,获得10
16秒前
16秒前
aaa发布了新的文献求助10
16秒前
ZRR完成签到,获得积分10
17秒前
冷艳的芹菜完成签到 ,获得积分10
17秒前
18秒前
情怀的应助被龙魂采纳,获得10
18秒前
蓝天的应助被奇思妙想安德鲁采纳,获得10
20秒前
我是老大的应助被传统的阙德采纳,获得10
20秒前
syy发布了新的文献求助10
20秒前
丘比特的应助被王小牛仔采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158056
求助须知:如何正确求助?哪些是违规求助? 9553944
关于积分的说明 21716733
捐赠科研通 7747388
什么是DOI,文献DOI怎么找? 3426934
关于科研通互助平台的介绍 2551676
邀请新用户注册赠送积分活动 2471038